Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
82.00
Ask:
87.00
Spread: 5.00 (6.098%)
Market Cap: £85.91m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Board composition and General Meeting update

29 May 2025 07:00

RNS Number : 5076K
Inspecs Group PLC
29 May 2025
 

29 May 2025

 

Inspecs Group plc

 

Board composition and General Meeting update

 

Inspecs Group plc ("Inspecs", the "Company" and together with its subsidiary undertakings, the "Group"), a leading designer, manufacturer and distributor of eyewear (sunglasses, optical frames, lenses and low vision products), announces the following updates on Board composition and the Requisition of a General Meeting (as announced on 14 May 2025).

 

Board composition

 

The Board is making good progress with its formal search, supported by a leading executive search firm, for a new Independent Non-Executive Chair ("Chair") to succeed Robin Totterman. Candidate interviews are underway, and the Board expects to make an appointment no later than the end of July 2025.

 

The Group announces today that Robin Totterman will step down from the role of Executive Chair at this year's AGM on 3 June, with Christopher Hancock, the Company's Senior Independent Director, becoming Interim Chair until the appointment of the new Chair. Robin has also notified the Board of his intention to step-down as a Director of the Board on 31 December 2025, providing a suitable time period for an orderly transfer of responsibilities.

 

The search for a new Chief Financial Officer is also progressing well, and the Board expects this to be finalised following the appointment of the new Chair.

 

General Meeting update

 

Further to the announcement on 14 May 2025 regarding the receipt of a notice requisitioning a general meeting of the Company (the "Requisition Notice"), the Group announces that Downing LLP has agreed to withdraw its Requisition Notice.

 

Robin Totterman, Founder and Executive Chair of Inspecs, said:

 

"As the founder of the business and a significant shareholder, my commitment to the long-term success of the Company remains unwavering. It is my intention to step down from the Board on 31 December 2025 and until then, my focus is on ensuring a smooth and stable transition, helping to deliver an improved business performance, and I remain dedicated to supporting the Company and its employees through this important phase."

 

Capitalised words and expressions not otherwise defined in this announcement shall have the meaning given in the announcement made by the Company on 14 May 2025.

 

For further information please contact:

 

Inspecs Group plc

Richard Peck (CEO)

Chris Kay (CFO)

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

George Sellar

Andrew Clark

Tel: +44 (0) 20 7418 8900

FTI Consulting (Financial PR)

Alex Beagley

Harriet Jackson

Amy Goldup

Tel: +44 (0) 20 3727 1000

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). The person responsible for making this announcement is Richard Peck, CEO.

 

About Inspecs Group plc

INSPECS is a leading provider of eyewear solutions to the global eyewear market. The Group produces a broad range of eyewear frames, low vision aids and lenses, covering optical, sunglasses and safety, which are either "Branded" (under licence or under the Group's own proprietary brands), or "OEM" (unbranded or private label on behalf of retail customers).

 

INSPECS is building a global eyewear business through its vertically integrated business model. Its continued growth is underpinned by increasing the penetration of its own-brand portfolio, worldwide distribution, growing retail presence, maximising group synergies and its global network, expanding its manufacturing capacity and scaling the research and development department as it develops new and innovative eyewear products. The Group has operations across the globe: with offices and subsidiaries in the UK, Germany, Portugal, Scandinavia, the US and China (including Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy.

 

INSPECS customers are global optical and non-optical retailers, global distributors and independent opticians. Its distribution network covers over 80 countries and reaches approximately 75,000 points of sale.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKFBPDBKBNPB
Date   Source Headline
19th May 20269:14 amRNSHolding(s) in Company
19th May 20267:00 amRNSBoard Changes
18th May 20267:00 amRNSBoard Changes
18th May 20267:00 amRNSOffer Closed
13th May 20267:00 amRNSFinal Results for the year ended 31 December 2025
1st May 20265:00 pmRNSClosure of the Offer
24th Mar 20267:00 amRNSAcceptance Level Update
18th Mar 202611:42 amRNSHolding(s) in Company
17th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
17th Mar 20269:16 amRNSForm 8.3 - INSPECS GROUP PLC
17th Mar 20267:45 amRNSDisclosure Table
17th Mar 20267:45 amRNSDisclosure Table
17th Mar 20267:00 amRNSDay 21 Acceptance Level Update
17th Mar 20267:00 amRNSDay 21 Acceptance Level Update
16th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
16th Mar 20268:44 amRNSForm 8.3 - INSPECS GROUP PLC
13th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
13th Mar 20267:00 amRNSOffer Declared Unconditional
13th Mar 20267:00 amRNSOffer Declared Unconditional
11th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
10th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
10th Mar 202610:40 amRNSHolding(s) in Company
10th Mar 20268:54 amRNSForm 8.3 - INSPECS GROUP PLC
9th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
9th Mar 20269:17 amRNSForm 8.3 - INSPECS GROUP PLC
6th Mar 20261:02 pmRNSForm 8.3 - Inspecs Group Plc
6th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
6th Mar 20269:26 amRNSForm 8.3 - INSPECS GROUP PLC
5th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
5th Mar 20269:32 amRNSForm 8.3 - INSPECS GROUP PLC
4th Mar 20265:00 pmRNSSatisfaction of NSIA Condition
4th Mar 20261:20 pmRNSAIM Rules Confirmation
4th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
4th Mar 20269:30 amRNSForm 8.3 - INSPECS GROUP PLC
4th Mar 20268:34 amBUSForm 8.3 - Inspecs Group Plc
3rd Mar 20265:22 pmRNSHolding(s) in Company
3rd Mar 20264:38 pmRNSForm 8.3 - Inspecs Group PLC
3rd Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
2nd Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
27th Feb 20261:09 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
26th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
25th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
25th Feb 20269:10 amGNWForm 8.3 - Inspecs Group Plc
23rd Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
23rd Feb 202611:46 amRNSHolding(s) in Company
23rd Feb 202611:30 amRNSPublication of the Offer Document
20th Feb 20266:32 pmRNSSwitch to a Takeover Offer
20th Feb 20266:01 pmRNSSwitch to a Takover Offer
20th Feb 20264:30 pmRNSForm 8.3 - INSPECS GROUP PLC
20th Feb 20264:01 pmBUSForm 8.3

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.